GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Operating Margin %

Hisamitsu Pharmaceutical Co (TSE:4530) Operating Margin % : 10.81% (As of Nov. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Hisamitsu Pharmaceutical Co's Operating Income for the three months ended in Nov. 2023 was 円3,874 Mil. Hisamitsu Pharmaceutical Co's Revenue for the three months ended in Nov. 2023 was 円35,850 Mil. Therefore, Hisamitsu Pharmaceutical Co's Operating Margin % for the quarter that ended in Nov. 2023 was 10.81%.

Warning Sign:

Hisamitsu Pharmaceutical Co Inc operating margin has been in a 5-year decline. The average rate of decline per year is -12%.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Operating Margin % or its related term are showing as below:

TSE:4530' s Operating Margin % Range Over the Past 10 Years
Min: 7.77   Med: 14.32   Max: 18.15
Current: 9.29


TSE:4530's Operating Margin % is ranked better than
60.26% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 6.1 vs TSE:4530: 9.29

Hisamitsu Pharmaceutical Co's 5-Year Average Operating Margin % Growth Rate was -12.00% per year.

Hisamitsu Pharmaceutical Co's Operating Income for the three months ended in Nov. 2023 was 円3,874 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Nov. 2023 was 円13,167 Mil.


Hisamitsu Pharmaceutical Co Operating Margin % Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Operating Margin % Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.12 9.32 7.77 9.04 9.29

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.49 13.59 11.57 10.81 2.31

Competitive Comparison of Hisamitsu Pharmaceutical Co's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Operating Margin % falls into.



Hisamitsu Pharmaceutical Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Hisamitsu Pharmaceutical Co's Operating Margin % for the fiscal year that ended in Feb. 2024 is calculated as

Operating Margin %=Operating Income (A: Feb. 2024 ) / Revenue (A: Feb. 2024 )
=13167 / 141706
=9.29 %

Hisamitsu Pharmaceutical Co's Operating Margin % for the quarter that ended in Nov. 2023 is calculated as

Operating Margin %=Operating Income (Q: Nov. 2023 ) / Revenue (Q: Nov. 2023 )
=3874 / 35850
=10.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (TSE:4530) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Hisamitsu Pharmaceutical Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines